11. 2022-RA-324-ESGO Phase 2 results from the LIO-1 STUDY (NCT04042116; ENGOT-GYN3/AGO/LIO): efficacy and safety of lucitanib + nivolumab in patients with advanced gynaecological malignancies. (20th October 2022) Authors: Concin, Nicole; Patel, Manish R; Makker, Vicky; Oaknin, Ana; Pignata, Sandro; Backes, Floor J; González-Martín, Antonio; Eskander, Ramez N; Pothuri, Bhavana; Richardson, Debra L; Secord, Angeles Alvarez; van Nieuwenhuysen, Els; Liu, Joyce F; Musa, Fernanda; Penson, Richard T; Wride, Kenton; Dusek... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. 2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine. (20th October 2022) Authors: Oaknin, Ana; Lorusso, Domenica; Oza, Amit; Colombo, Nicoletta; van Gorp, Toon; O'Malley, David; Banerjee, Susana; Murphy, Conleth; Harter, Philipp; Konecny, Gottfried; Kaminsky, Marie-Christine; Method, Michael; Wang, Jiuzhou; Coleman, Robert L; Birrer, Michael; Matulonis, Ursula; Moore, Kathleen Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial. (20th October 2022) Authors: Banerjee, Susana; André, Thierry; Berton, Dominique; Ellard, Susan L; Jimenez, Begoña; Samouëlian, Vanessa; Gilbert, Lucy; Boni, Valentina; Han, Xinwei; Antony, Grace; Veneris, Jennifer; Oaknin, Ana Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. 385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study. (4th December 2020) Authors: Oaknin, Ana; Gilbert, Lucy; Tinker, Anna V; Sabatier, Renaud; Boni, Valentina; O'malley, David M; Ghamande, Sharad; Guo, Wei; Im, Ellie; Pothuri, Bhavana Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. 39/#452 Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study. (4th December 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan; Pikiel, Joanna; Mirza, Mansoor; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Veneris, Jennife... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study. (4th December 2020) Authors: Colombo, Nicoletta; Bradley, William; Moore, Kathleen; González-Martín, Antonio; Scambia, Giovanni; Oaknin, Ana; Friedlander, Michael; Lowe, Elizabeth; Rowe, Phil; Disilvestro, Paul Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. 518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers. (4th December 2020) Authors: Banerjee, Susana; Oaknin, Ana; Sanchez-Simon, Inmaculada; Salgado, Alfonso Cortes; Patel, Sandip Pravin; Oza, Amit; Das, Mayukh; Kourtesis, Panagiotis; Ascierto, Maria Libera; Diamond, Jennifer R Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗